Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Hard CopyAdd to Basket
Electronic (Online Access)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Sanofi-Aventis Generics Company Intelligence Report

Espicom Business Intelligence Ltd, Jan 2011, Pages: 10


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Although primarily a branded business, sanofi-aventis does have a generics segment, which this profile focuses on. The firm's forays into generics came initially through its Winthrop subsidiary, but have expanded in recent years, most notably with the acquisition of the Czech Republic-based Zentiva.

Winthrop is concentrated in the major EU markets, including France, Germany and the United Kingdom. However, it is active in other markets, and sees Latin America as an area for expansion.

Prior to its acquisition, Zentiva claimed to be one of the largest pharmaceutical firms in Central and Eastern Europe, with leading market positions in the Czech Republic, Turkey, Romania and Slovakia.

For the year ended 31st December 2009, sanofi-aventis reported that its Generics business had achieved sales of 1,012 million euros (US$1,411.4 million), reflecting the consolidation of its generics businesses.

The firm is expanding its generics presence in Latin America. In January 2009, sanofi-aventis acquired Mexico's Kendrick, and in April 2009 it acquired Brazil's Medley.

Executive Summary


Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the company's active product lines and ANDA approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation.



Customers who bought this item also bought

Zentiva Generics Company Intelligence Report

Sanofi-Aventis Market Share Analysis

sanofi-aventis - Pipeline - Products - Performance - Potential

The Future of Czech Republic Oil Refining Market to 2015- Forecasts and Insights into Czech Republic Refining Markets, Companies, Refineries

CEZ a.s. -Overview, Contact Details, locations, Key executives, Power Plant Information, Business Description and SWOT Analysis

Zentiva, a.s. (formerly Leciva a.s.)-Detailed Product Pipeline

Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - H2 2011

Sanofi-Aventis SA - Strategy, SWOT, and Corporate Finance Report

Crawler/Wheeled Excavators in Czech Republic to 2015: Market Snapshot

Mini Excavators in Czech Republic to 2015: Market Snapshot



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds